NASDAQ:IKT

Inhibikase Therapeutics, Inc.

Read IKT's Filings Free

Company facts

Most recent report
10-Q, filed Aug 11, 2026
Incorporated
Delaware
Filings on record
363 filings
On EDGAR
CIK 1750149
Fiscal year ends
December
Filer status
Non-accelerated filer Smaller reporting company

Financials 8 of 25

News 8 of 67

Prospectuses and Registrations 8 of 39

Proxies 8 of 24

Ownership 8 of 150

Other 8 of 58

Everything here comes from Inhibikase Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.